Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donaldson, J. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donaldson, J. O.
NEUROLOGY 1981;31:877
© 1981 American Academy of Neurology

Pathogenesis of pseudotumor cerebri syndromes

James O. Donaldson, M.D.

Department of Neurology, University of Connecticut School of Medicine, Farmington, CT.

Intracrania1 hypertension in the absence of an intracranial mass lesion or hydrocephalus can be caused by an alteration of one or more of the four determinants of cerebrospinal fluid (CSF) pressure: (1) intrasagittal sinus pressure, (2) resistance of arachnoid villi to the egress of CSF, (3) rate of production of CSF, and (4) compliance of the CSF space. The pseudotumor cerebri syndrome of obese young women may be caused partially by increased CSF production. Estrone (produced by the conversion of androstenedione by adipocytes) probably induces the menstrual irregularities of these women and may affect CSF secretion. Pseudotumor cerebri syndromes associated with other conditions may be separated into pathogenic categories.

Address correspondence and reprint requests to Dr. Donaldson, Department of Neurology, University of Connecticut Health Center, Farmington, CT 06032.

Accepted for publication September 29, 1980.




This article has been cited by other articles:


Home page
EDUCATION AND PRACTICEHome page
Y Y Matthews
Drugs used in childhood idiopathic or benign intracranial hypertension
Arch. Dis. Child. Ed. Pract., February 1, 2008; 93(1): 19 - 25.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J N P Higgins, C Cousins, B K Owler, N Sarkies, and J D Pickard
Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting
J. Neurol. Neurosurg. Psychiatry, December 1, 2003; 74(12): 1662 - 1666.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C. Cognard, A. Casasco, M. Toevi, E. Houdart, J. Chiras, and J.-J. Merland
Dural arteriovenous fistulas as a cause of intracranial hypertension due to impairment of cranial venous outflow
J. Neurol. Neurosurg. Psychiatry, September 1, 1998; 65(3): 308 - 316.
[Abstract] [Full Text]


Home page
Arch. Dis. Child.Home page
D Soler, T Cox, P Bullock, D M Calver, and R O Robinson
Diagnosis and management of benign intracranial hypertension
Arch. Dis. Child., January 1, 1998; 78(1): 89 - 94.
[Full Text]


Home page
Arch NeurolHome page
K. Radhakrishnan, J. E. Ahlskog, S. A. Cross, L. T. Kurland, and W. M. O'Fallon
Idiopathic Intracranial Hypertension (Pseudotumor Cerebri) Descriptive Epidemiology in Rochester, Minn, 1976 to 1990
Arch Neurol, January 1, 1993; 50(1): 78 - 80.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. Marcelis and S. D. Silberstein
Idiopathic Intracranial Hypertension Without Papilledema
Arch Neurol, April 1, 1991; 48(4): 392 - 399.
[Abstract] [PDF]


Home page
Arch NeurolHome page
P. S. Sorensen, F. Gjerris, and B. Svenstrup
Endocrine Studies in Patients With Pseudotumor Cerebri: Estrogen Levels in Blood and Cerebrospinal Fluid
Arch Neurol, September 1, 1986; 43(9): 902 - 906.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by AAN Enterprises, Inc.